Biomaterial Database

Potentiation of the antifungal effects of antibiotics by amphotericin B. 1972

C N Kwan, and G Medoff, and G S Kobayashi, and D Schlessinger, and H J Raskas

Amphotericin B was found to potentiate the antifungal effects of mycophenolic acid glucuronide, tetracycline, and actinomycin D by increasing the penetration of these antibiotics through the fungal cytoplasmic membrane. Because the fungi were over 100 times more susceptible than animal cells to these effects of amphotericin B, these observations might have clinical application.

UI	MeSH Term	Description	Entries
D002462	Cell Membrane	The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.	Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004357	Drug Synergism	The action of a drug in promoting or enhancing the effectiveness of another drug.	Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000666	Amphotericin B	Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.	Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.	Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012441	Saccharomyces cerevisiae	A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement.	Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker

Related Publications

C N Kwan, and G Medoff, and G S Kobayashi, and D Schlessinger, and H J Raskas

Amphotericin B and other polyenic antifungal antibiotics.

August 1969, American journal of clinical pathology,

C N Kwan, and G Medoff, and G S Kobayashi, and D Schlessinger, and H J Raskas

Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.

November 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

C N Kwan, and G Medoff, and G S Kobayashi, and D Schlessinger, and H J Raskas

Potentiation of antifungal activity of amphotericin B by essential oil from Cinnamomum cassia.

January 2006, Phytotherapy research : PTR,

C N Kwan, and G Medoff, and G S Kobayashi, and D Schlessinger, and H J Raskas

Potentiation of antifungal effect of amphotericin B by squalene, an intermediate for sterol biosynthesis.

February 1982, The Journal of antibiotics,

C N Kwan, and G Medoff, and G S Kobayashi, and D Schlessinger, and H J Raskas

Effects of polyene antifungal antibiotics on the heart: a study with amphotericin B and endomycin.

September 1965, The Indian journal of medical research,

C N Kwan, and G Medoff, and G S Kobayashi, and D Schlessinger, and H J Raskas

Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group.

August 2013, Antimicrobial agents and chemotherapy,